GlassScriptPhysician profile
Jo Ellyn Dyson
NPI 1790797595
$2,019.85
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,280 · 2022: $740.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $600.89 | 2021-2022 | |
| Lilly USA, LLC | $252.97 | 2021-2022 | |
| Janssen Biotech, INC. | $198.07 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $170.65 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $159.17 | 2021-2022 | |
| Amgen INC. | $130.29 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $115.00 | 2021 | |
| Organogenesis INC. | $80.32 | 2021-2022 | |
| Medtronic, INC. | $75.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $60.71 | 2021 | |
| Galderma Laboratories, L.P. | $48.25 | 2021-2022 | |
| Genzyme Corporation | $47.93 | 2021-2022 | |
| Genentech USA, INC. | $36.90 | 2021 | |
| Pfizer INC. | $24.71 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.51 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jo Ellyn Dyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.